Concord Biotech, 543960, CONCORDBIO Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,254.87
52.89
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17,246.41
0.53%
10.37

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.60
-
12.57

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.58
-
9.55

PAT CAGR (%)

10 Years
5 Years
3 Years

15.80
-
20.77

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 29.45 35.57 46.35 59.14
P/E Ratio 70.21 58.13 44.61 34.96
Revenue 998 1212 1498 1825
EBITDA 432 511 657 833
Net Income 308 372 484 618
ROA 19.2 20 22 23
P/Bk Ratio 14.17 11.96 9.92 8.11
ROE 21.88 21.44 23.24 23.69
FCFF 179.9 242.98 290.77 393.61
FCFF Yield 0.84 1.14 1.36 1.84

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 244.22 240.80 1.42% 310.18 262.35 18.23% 215.80 194.83 10.76% 318.97 272.58 17.02%
Expenses 146.27 134.87 8.45% 173.50 143.16 21.19% 134.52 122.67 9.66% 184.68 143.52 28.68%
EBITDA 97.95 105.93 -7.53% 136.68 119.19 14.67% 81.28 72.15 12.65% 134.29 129.06 4.05%
EBIDTM 40.11% 43.99% 44.06% 45.43% 37.66% 37.03% 42.10% 47.35%
Other Income 14.73 8.19 79.85% 10.03 8.13 23.37% 10.31 6.65 55.04% 10.81 12.20 -11.39%
Interest 0.10 0.50 -80.00% 0.10 0.84 -88.10% 0.24 0.75 -68.00% 0.46 1.45 -68.28%
Depreciation 13.26 13.54 -2.07% 13.31 13.29 0.15% 13.18 13.04 1.07% 13.72 14.18 -3.24%
PBT 99.32 100.09 -0.77% 133.29 113.18 17.77% 78.17 65.01 20.24% 130.92 125.62 4.22%
Tax 25.23 25.53 -1.18% 34.59 28.69 20.56% 19.93 16.54 20.50% 33.70 32.12 4.92%
PAT 74.09 74.55 -0.62% 98.70 84.49 16.82% 58.24 48.47 20.16% 97.22 93.51 3.97%
PATM 30.34% 30.96% 31.82% 32.21% 26.99% 24.88% 30.48% 34.30%
EPS 7.08 7.13 -0.70% 9.44 8.08 16.83% 5.57 4.63 20.30% 9.29 8.94 3.91%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 244.22 240.80 1.42% 310.18 262.35 18.23% 215.80 194.83 10.76% 318.97 272.58 17.02%
Expenses 146.27 134.87 8.45% 173.50 143.16 21.19% 134.52 122.67 9.66% 184.68 143.52 28.68%
EBITDA 97.95 105.93 -7.53% 136.68 119.19 14.67% 81.28 72.15 12.65% 134.29 129.06 4.05%
EBIDTM 40.11% 43.99% 44.06% 45.43% 37.66% 37.03% 42.10% 47.35%
Other Income 14.73 8.19 79.85% 10.03 8.13 23.37% 10.31 6.65 55.04% 10.81 12.20 -11.39%
Interest 0.10 0.50 -80.00% 0.10 0.84 -88.10% 0.24 0.75 -68.00% 0.46 1.45 -68.28%
Depreciation 13.26 13.54 -2.07% 13.31 13.29 0.15% 13.18 13.04 1.07% 13.72 14.18 -3.24%
PBT 99.32 100.09 -0.77% 133.29 113.18 17.77% 78.17 65.01 20.24% 130.92 125.62 4.22%
Tax 25.23 25.53 -1.18% 34.59 28.69 20.56% 19.93 16.54 20.50% 33.70 32.12 4.92%
PAT 74.09 74.55 -0.62% 98.70 84.49 16.82% 58.24 48.47 20.16% 97.22 93.51 3.97%
PATM 30.34% 30.96% 31.82% 32.21% 26.99% 24.88% 30.48% 34.30%
EPS 7.26 7.41 -2.02% 9.15 7.74 18.22% 5.70 5.21 9.40% 9.08 8.75 3.77%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,089.17 1,016.94 853.17 712.93 616.94 276.17 238.53 204.82 164.91 135.60 108.59 Net Sales Growth 12.22% 19.20% 19.67% 15.56% 123.39% 15.78% 16.46% 24.20% 21.62% 24.87% Cost Of Goods Sold 265.86 229.20 180.21 164.01 111.56 63.26 54.22 48.88 34.30 25.07 16.78 Gross Profit 823.31 787.74 672.96 548.92 505.37 212.91 184.31 155.93 130.61 110.53 91.81 GP Margin 75.59% 77.46% 78.88% 76.99% 81.92% 77.09% 77.27% 76.13% 79.20% 81.51% 84.55% Total Expenditure 638.97 584.75 504.59 439.01 289.01 140.63 127.67 119.26 88.75 69.85 49.51 Power & Fuel Cost - 104.97 97.65 71.64 39.86 26.89 28.90 29.45 25.71 21.27 15.15 % Of Sales - 10.32% 11.45% 10.05% 6.46% 9.74% 12.12% 14.38% 15.59% 15.69% 13.95% Employee Cost - 123.05 110.28 95.69 69.47 22.87 19.78 15.57 13.44 10.88 8.27 % Of Sales - 12.10% 12.93% 13.42% 11.26% 8.28% 8.29% 7.60% 8.15% 8.02% 7.62% Manufacturing Exp. - 31.23 38.44 32.45 21.97 12.42 12.32 12.35 8.45 7.00 4.99 % Of Sales - 3.07% 4.51% 4.55% 3.56% 4.50% 5.16% 6.03% 5.12% 5.16% 4.60% General & Admin Exp. - 54.73 45.72 31.09 22.52 8.72 6.53 6.42 3.54 2.59 1.81 % Of Sales - 5.38% 5.36% 4.36% 3.65% 3.16% 2.74% 3.13% 2.15% 1.91% 1.67% Selling & Distn. Exp. - 33.11 23.70 21.44 13.36 4.80 4.40 3.68 2.00 1.44 1.73 % Of Sales - 3.26% 2.78% 3.01% 2.17% 1.74% 1.84% 1.80% 1.21% 1.06% 1.59% Miscellaneous Exp. - 8.46 8.59 22.69 10.26 1.67 1.52 2.90 1.31 1.59 1.73 % Of Sales - 0.83% 1.01% 3.18% 1.66% 0.60% 0.64% 1.42% 0.79% 1.17% 0.71% EBITDA 450.20 432.19 348.58 273.92 327.93 135.54 110.86 85.56 76.16 65.75 59.08 EBITDA Margin 41.33% 42.50% 40.86% 38.42% 53.15% 49.08% 46.48% 41.77% 46.18% 48.49% 54.41% Other Income 45.88 33.78 35.31 23.42 13.81 4.58 5.51 2.83 5.31 2.58 3.81 Interest 0.90 3.18 9.80 6.13 1.05 0.32 0.82 0.70 0.30 0.41 0.35 Depreciation 53.47 53.59 54.03 50.05 27.52 10.46 9.67 11.43 10.14 8.97 7.26 PBT 441.70 409.19 320.05 241.16 313.17 129.34 105.88 76.25 71.04 58.95 55.28 Tax 113.45 104.46 81.93 62.59 77.83 42.09 35.63 21.83 21.65 17.17 16.00 Tax Rate 25.68% 25.53% 25.60% 25.95% 24.85% 32.54% 33.65% 28.63% 30.48% 29.13% 28.94% PAT 328.25 304.73 238.13 178.57 235.33 87.25 70.25 54.41 49.39 41.78 39.28 PAT before Minority Interest 328.25 304.73 238.13 178.57 235.33 87.25 70.25 54.41 49.39 41.78 39.28 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 30.14% 29.97% 27.91% 25.05% 38.14% 31.59% 29.45% 26.56% 29.95% 30.81% 36.17% PAT Growth 9.05% 27.97% 33.35% -24.12% 169.72% 24.20% 29.11% 10.16% 18.21% 6.36% EPS 31.38 29.13 22.77 17.07 22.50 8.34 6.72 5.20 4.72 3.99 3.76

Description TTM Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 1,089.17 1,016.94 853.17 712.93 616.94 Net Sales Growth 12.22% 19.20% 19.67% 15.56% Cost Of Goods Sold 265.86 229.20 180.21 164.01 111.56 Gross Profit 823.31 787.74 672.96 548.92 505.38 GP Margin 75.59% 77.46% 78.88% 76.99% 81.92% Total Expenditure 638.97 584.75 504.59 439.01 289.01 Power & Fuel Cost - 104.97 97.65 71.64 39.86 % Of Sales - 10.32% 11.45% 10.05% 6.46% Employee Cost - 123.05 110.28 95.69 69.47 % Of Sales - 12.10% 12.93% 13.42% 11.26% Manufacturing Exp. - 31.23 38.44 32.48 21.97 % Of Sales - 3.07% 4.51% 4.56% 3.56% General & Admin Exp. - 54.73 45.72 31.09 22.52 % Of Sales - 5.38% 5.36% 4.36% 3.65% Selling & Distn. Exp. - 33.11 23.70 21.44 13.36 % Of Sales - 3.26% 2.78% 3.01% 2.17% Miscellaneous Exp. - 8.46 8.59 22.66 10.26 % Of Sales - 0.83% 1.01% 3.18% 1.66% EBITDA 450.20 432.19 348.58 273.92 327.93 EBITDA Margin 41.33% 42.50% 40.86% 38.42% 53.15% Other Income 45.88 33.78 35.31 23.42 13.81 Interest 0.90 3.18 9.80 6.13 1.05 Depreciation 53.47 53.59 54.03 50.05 27.52 PBT 441.70 409.19 320.05 241.16 313.17 Tax 113.45 104.46 81.93 62.59 77.83 Tax Rate 25.68% 25.53% 25.60% 25.95% 24.85% PAT 328.25 308.10 240.09 174.93 235.34 PAT before Minority Interest 328.25 308.10 240.09 174.93 235.34 Minority Interest 0.00 0.00 0.00 0.00 0.00 PAT Margin 30.14% 30.30% 28.14% 24.54% 38.15% PAT Growth 9.05% 28.33% 37.25% -25.67% EPS 31.38 29.46 22.95 16.72 22.50

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Shareholder's Funds 1,525.25 1,291.98 1,107.16 999.67 226.47 185.52 146.30 111.20 77.28 64.87 Share Capital 10.46 10.46 9.51 9.51 9.21 4.60 4.60 4.60 2.30 2.53 Total Reserves 1,514.79 1,281.52 1,097.65 990.16 217.26 180.92 141.69 106.60 74.98 62.34 Non-Current Liabilities 31.91 32.13 54.40 77.43 10.53 9.03 7.94 7.97 5.90 10.01 Secured Loans 0.00 6.24 31.25 56.25 0.00 0.00 0.00 0.00 2.27 7.23 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.96 2.30 1.87 2.10 0.27 0.28 0.55 0.78 0.00 0.00 Current Liabilities 142.16 190.53 340.97 235.93 37.96 27.55 24.26 21.01 16.30 16.27 Trade Payables 94.44 93.80 83.11 46.40 15.38 9.03 6.95 5.22 8.35 4.10 Other Current Liabilities 38.32 60.26 62.70 53.58 3.93 2.28 3.58 6.45 1.54 1.22 Short Term Borrowings 0.00 0.00 4.34 5.10 4.97 3.62 6.59 3.86 0.00 0.00 Short Term Provisions 9.40 36.47 190.82 130.85 13.68 12.62 7.15 5.47 6.41 10.95 Total Liabilities 1,699.32 1,514.64 1,502.53 1,313.03 274.96 222.10 178.50 140.18 99.48 91.15 Net Block 575.32 592.98 572.98 546.22 98.73 81.62 69.48 63.94 40.42 32.99 Gross Block 828.31 792.80 718.85 644.29 161.05 132.77 110.61 96.21 65.56 52.98 Accumulated Depreciation 253.00 199.81 145.87 98.08 62.31 51.15 41.14 32.28 25.14 19.99 Non Current Assets 803.08 786.95 869.87 705.89 113.02 88.35 87.86 73.36 52.46 39.43 Capital Work in Progress 211.48 172.70 74.16 17.95 8.02 3.97 14.42 7.00 12.04 6.44 Non Current Investment 0.67 0.79 0.92 0.67 0.56 0.56 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 12.81 11.61 220.99 140.61 5.72 2.00 3.77 2.41 0.00 0.00 Other Non Current Assets 2.81 8.87 0.82 0.45 0.00 0.21 0.19 0.00 0.00 0.00 Current Assets 896.23 727.70 632.67 607.15 161.94 133.75 90.64 66.81 47.03 51.72 Current Investments 243.70 136.93 73.47 140.99 0.00 2.00 2.02 0.00 3.01 12.03 Inventories 207.95 212.31 195.12 153.61 39.41 34.36 23.66 18.75 14.04 14.99 Sundry Debtors 349.61 273.76 232.17 177.52 100.35 85.43 54.83 30.17 23.82 10.91 Cash & Bank 47.02 43.45 88.93 60.82 2.67 1.53 1.04 12.22 0.61 0.23 Other Current Assets 47.94 45.57 32.53 40.37 19.50 10.42 9.09 5.67 5.54 13.55 Short Term Loans & Adv. 21.12 15.68 10.44 33.85 10.58 2.76 2.83 2.07 5.34 13.41 Net Current Assets 754.08 537.17 291.70 371.22 123.98 106.20 66.38 45.81 30.73 35.45 Total Assets 1,699.31 1,514.65 1,502.54 1,313.04 274.96 222.10 178.50 140.17 99.49 91.15

Description Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 1,526.65 1,290.00 1,103.22 999.37 Share Capital 10.46 10.46 9.51 9.51 Total Reserves 1,516.18 1,279.54 1,093.71 989.86 Non-Current Liabilities 31.91 32.13 54.40 77.43 Secured Loans 0.00 6.24 31.25 56.25 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 1.96 2.30 1.87 2.10 Current Liabilities 142.16 191.84 344.24 235.93 Trade Payables 94.44 93.80 83.11 46.40 Other Current Liabilities 38.32 61.57 65.98 53.58 Short Term Borrowings 0.00 0.00 4.34 5.10 Short Term Provisions 9.40 36.47 190.82 130.85 Total Liabilities 1,700.72 1,513.97 1,501.86 1,312.73 Net Block 575.32 592.98 572.98 546.22 Gross Block 828.31 792.80 718.85 645.33 Accumulated Depreciation 253.00 199.81 145.87 99.11 Non Current Assets 804.48 786.28 869.20 705.59 Capital Work in Progress 211.48 172.70 74.16 17.95 Non Current Investment 2.06 0.12 0.26 0.37 Long Term Loans & Adv. 12.81 11.61 220.99 140.61 Other Non Current Assets 2.81 8.87 0.82 0.45 Current Assets 896.23 727.70 632.67 607.15 Current Investments 243.70 136.93 73.47 140.99 Inventories 207.95 212.31 195.12 153.61 Sundry Debtors 349.61 273.76 232.17 177.52 Cash & Bank 47.02 43.45 88.93 60.82 Other Current Assets 47.94 45.57 32.53 40.37 Short Term Loans & Adv. 21.12 15.68 10.44 33.85 Net Current Assets 754.08 535.86 288.42 371.22 Total Assets 1,700.71 1,513.98 1,501.87 1,312.74

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Cash From Operating Activity 265.47 246.00 207.47 166.81 39.81 21.53 16.14 36.04 34.70 18.96 PBT 409.19 320.05 241.16 313.17 76.25 71.04 58.95 55.28 55.92 14.21 Adjustment 40.80 48.51 49.16 17.59 15.07 8.58 8.18 7.52 5.26 5.08 Changes in Working Capital -81.18 -52.29 -22.06 -88.77 -24.01 -41.68 -33.34 -11.66 -9.66 3.93 Cash after chg. in Working capital 368.82 316.28 268.26 241.99 67.30 37.94 33.79 51.14 51.53 23.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -103.35 -70.28 -60.78 -75.18 -27.49 -16.41 -17.64 -15.10 -16.82 -4.39 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 Cash From Investing Activity -154.61 -157.95 -111.79 -195.20 -31.41 -10.85 -21.79 -22.40 -8.71 -20.05 Net Fixed Assets -74.29 -172.49 -130.77 -493.17 -32.33 -11.71 -21.82 -25.61 -18.18 -8.21 Net Investments -106.65 -63.33 67.27 -141.10 2.00 -0.54 -2.02 3.01 9.02 -12.03 Others 26.33 77.87 -48.29 439.07 -1.08 1.40 2.05 0.20 0.45 0.19 Cash from Financing Activity -99.21 -85.22 -100.16 31.12 -9.32 -9.82 -3.83 -1.98 -25.61 0.14 Net Cash Inflow / Outflow 11.64 2.83 -4.48 2.74 -0.91 0.85 -9.48 11.66 0.38 -0.95 Opening Cash & Equivalents 3.50 0.67 5.14 2.41 3.52 2.66 12.14 0.57 0.23 1.18 Closing Cash & Equivalent 15.14 3.50 0.67 5.14 2.60 3.52 2.66 12.22 0.61 0.23

Description Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 265.47 246.00 207.47 166.82 PBT 412.56 322.01 237.52 312.72 Adjustment 37.43 46.55 52.80 18.04 Changes in Working Capital -81.18 -52.29 -22.05 -88.76 Cash after chg. in Working capital 368.82 316.28 268.26 241.99 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -103.35 -70.28 -60.78 -75.18 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -154.61 -157.95 -111.79 -195.21 Net Fixed Assets -74.29 -172.49 -130.77 Net Investments -106.65 -63.33 67.27 Others 26.33 77.87 -48.29 Cash from Financing Activity -99.21 -85.22 -100.16 31.12 Net Cash Inflow / Outflow 11.64 2.83 -4.48 2.74 Opening Cash & Equivalents 3.50 0.67 5.14 2.41 Closing Cash & Equivalent 15.14 3.50 0.67 5.14

Financial Ratios

Standalone /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 145.80 123.50 105.83 95.56 246.02 403.07 317.85 241.60 335.83 256.06 ROA 18.96% 15.78% 12.68% 20.89% 21.89% 24.66% 26.22% 32.78% 38.53% 11.59% ROE 21.63% 19.85% 16.95% 26.60% 26.42% 29.77% 32.45% 41.68% 51.67% 16.10% ROCE 28.89% 26.48% 21.94% 33.00% 36.59% 41.71% 44.18% 56.95% 74.38% 22.42% Fixed Asset Turnover 1.25 1.13 1.05 1.29 1.44 1.42 1.35 1.39 1.79 1.06 Receivable days 111.87 108.22 104.87 106.80 160.03 148.42 111.49 87.54 59.62 67.04 Inventory Days 75.42 87.15 89.27 78.34 63.55 61.40 55.63 53.17 49.83 113.67 Payable days 149.88 179.16 144.10 192.42 36.90 30.92 29.60 45.56 48.65 29.49 Cash Conversion Cycle 37.41 16.22 50.04 -7.28 186.68 178.90 137.51 95.15 60.81 151.22 Total Debt/Equity 0.00 0.02 0.05 0.09 0.02 0.02 0.05 0.04 0.03 0.11 Interest Cover 129.52 33.65 40.31 300.20 109.58 238.74 144.64 156.79 119.05 19.33

Description Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 145.93 123.31 105.45 95.52 ROA 19.17% 15.92% 12.43% 20.89% ROE 21.88% 20.06% 16.64% 26.60% ROCE 29.13% 26.70% 21.66% 33.01% Fixed Asset Turnover 1.25 1.13 1.05 1.29 Receivable days 111.87 108.22 104.87 106.80 Inventory Days 75.42 87.15 89.27 78.34 Payable days 149.88 179.16 144.10 192.42 Cash Conversion Cycle 37.41 16.22 50.04 -7.28 Total Debt/Equity 0.00 0.02 0.05 0.09 Interest Cover 130.57 33.85 39.72 300.11

Top Investors:

nishtha jhunjhunwala discretionary trust

aryaman jhunjhunwala discretionary trust

aryavir jhunjhunwala discretionary trust

government pension fund global

amal n parikh

max life insurance company limited a/c reversionary bonus participating - equity

tata aia life insurance co ltd unit linked multi cap fund

ravindra raichand dharamshi

chanakya corporate services private limited

invesco india flexi cap fund

Annual Reports:

News Update:

Concord Biotech reports marginal decline in Q3 consolidated net profit
14th Feb 2025, 14:51 PM

Total consolidated income of the company increased marginally by 4% at Rs 258.95 crore for Q3FY25
Read More
Concord biotech to acquire 26% stake of Clean Max from CMEESPL
17th Jan 2025, 14:42 PM

This strategic investment reinforces the Company’s commitment to environmental responsibility
Read More

Concord Biotech Ltd.

Pharmaceuticals & Drugs

BSE: 543960 | NSE: CONCORDBIO

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Concord Biotech Ltd.

Pharmaceuticals & Drugs

BSE: 543960 | NSE: CONCORDBIO

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: